Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Co... von HIRONAKA, Shuichi, UEDA, Shinya, ESAKI, Taito, NAGASE, Michitaka, FUJITANI, Kazumasa, YAMAGUCHI, Kensei, URA, Takashi, HAMAMOTO, Yasuo, MORITA, Satoshi, OKAMOTO, Isamu, BOKU, Narikazu, HYODO, Ichinosuke, YASUI, Hirofumi, NISHINA, Tomohiro, TSUDA, Masahiro, TSUMURA, Takehiko, SUGIMOTO, Naotoshi, SHIMODAIRA, Hideki, TOKUNAGA, Shinya, MORIWAKI, Toshikazu

Volltext

Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma von Hara, Hiroki, Tahara, Makoto, Daiko, Hiroyuki, Kato, Ken, Igaki, Hiroyasu, Kadowaki, Shigenori, Tanaka, Yoichi, Hamamoto, Yasuo, Matsushita, Hisayuki, Nagase, Michitaka, Hosoya, Yoshinori

Volltext

Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study i... von Aoki, Masahiko, Kadowaki, Shigenori, Takahashi, Naoki, Suzuki, Takeshi, Oshima, Kotoe, Ando, Takayuki, Yamamoto, Yoshiyuki, Kawakami, Kentaro, Kito, Yosuke, Matsumoto, Toshihiko, Shimozaki, Keitaro, Miyazaki, Yasuhiro, Yamaguchi, Toshifumi, Nagase, Michitaka, Tamura, Takao, Amanuma, Yusuke, Esaki, Taito, Miura, Yuji, Akiyoshi, Kohei, Baba, Eishi, Makiyama, Akitaka, Negoro, Yuji, Nakashima, Koji, Sugimoto, Naotoshi, Nagashima, Kengo, Shoji, Hirokazu, Boku, Narikazu

Volltext

A Multicenter Phase II Trial of S-1 With Concurrent Radiation Therapy for Locally Advanced Pancreatic Cancer von Ikeda, Masafumi, MD, Ioka, Tatsuya, MD, Ito, Yoshinori, MD, Yonemoto, Naohiro, MPH, Nagase, Michitaka, MD, Yamao, Kenji, MD, Miyakawa, Hiroyuki, MD, Ishii, Hiroshi, MD, Furuse, Junji, MD, Sato, Keiko, PhD, Sato, Tosiya, PhD, Okusaka, Takuji, MD

Volltext

Phase II Study of Radiotherapy Employing Proton Beam for Hepatocellular Carcinoma von KAWASHIMA, Mitsuhiko, FURUSE, Junji, NISHIO, Teiji, KONISHI, Masaru, ISHII, Hiroshi, KINOSHITA, Taira, NAGASE, Michitaka, NIHEI, Keiji, OGINO, Takashi

Volltext

First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study von Makiyama, Akitaka, Kunieda, Kenji, Noguchi, Masaaki, Kajiwara, Takeshi, Tamura, Takao, Takeda, Koji, Sugiyama, Junko, Minashi, Keiko, Moriwaki, Toshikazu, Sugimoto, Naotoshi, Nagase, Michitaka, Negoro, Yuji, Tsuda, Takashi, Shimodaira, Hideki, Okano, Naohiro, Tsuji, Akihito, Sakai, Daisuke, Yanagihara, Kazuhiro, Ueda, Shinya, Tamura, Shingo, Otsu, Satoshi, Honda, Takuya, Matsushita, Yuzo, Okuno, Tatsuya, Kashiwada, Tomomi, Nozaki, Akira, Ebi, Masahide, Okuda, Hiroyuki, Shimokawa, Mototsugu, Hironaka, Shuichi, Hyodo, Ichinosuke, Baba, Eishi, Boku, Narikazu, Muro, Kei, Esaki, Taito

Volltext

A Multi-center Retrospective Analysis of Survival Benefits of Chemotherapy for Unresectable Biliary Tract Cancer von Yonemoto, Naohiro, Furuse, Junji, Okusaka, Takuji, Yamao, Kenji, Funakoshi, Akihiro, Ohkawa, Shinichi, Boku, Narikazu, Tanaka, Katsuaki, Nagase, Michitaka, Saisho, Hiromitsu, Sato, Tosiya

Volltext

First‐line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: A phase II study von Tsuji, Yasushi, Satoh, Taroh, Tsuji, Akihito, Muro, Kei, Yoshida, Motoki, Nishina, Tomohiro, Nagase, Michitaka, Komatsu, Yoshito, Kato, Takeshi, Miyata, Yoshinori, Mizutani, Naoko, Hashigaki, Satoshi, Lechuga, Maria Jose, Denda, Tadamichi

Volltext

A randomized phase III trial of mFOLFOX6 plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment for metastatic colorectal cancer: West Japan Oncology Group study... von Yamazaki, Kentaro, Nagase, Michitaka, Tamagawa, Hiroshi, Ueda, Shinya, Tamura, Takao, Murata, Kohei, Tsuda, Takashi, Baba, Eishi, Tsuda, Masahiro, Moriwaki, Toshikazu, Esaki, Taito, Tsuji, Yasushi, Muro, Kei, Taira, Koichi, Denda, Tadamichi, Tsushima, Takahiro, Ando, Masahiko, Morita, Satoshi, Boku, Narikazu, Hyodo, Ichinosuke

Volltext

Retrospective analysis of the international standard-dose FOLFIRI (plus bevacizumab) regimen in Japanese patients with unresectable advanced or recurrent colorectal carcinoma von Nishi, Tomohiro, Hamamoto, Yasuo, Warita, Etsuko, Miyamoto, Junko, Akutsu, Noriyuki, Yamanaka, Yasuhiro, Nagase, Michitaka, Fujii, Hirofumi

Volltext

Randomized phase III study of irinotecan (CPT-11) versus weekly paclitaxel (wPTX) for advanced gastric cancer (AGC) refractory to combination chemotherapy (CT) of fluoropyrimidine... von Ueda, Shinya, Hironaka, Shuichi, Yasui, Hirofumi, Nishina, Tomohiro, Tsuda, Masahiro, Tsumura, Takehiko, Sugimoto, Naotoshi, Shimodaira, Hideki, Tokunaga, Shinya, Moriwaki, Toshikazu, Esaki, Taito, Nagase, Michitaka, Fujitani, Kazumasa, Yamaguchi, Kensei, Ura, Takashi, Hamamoto, Yasuo, Morita, Satoshi, Okamoto, Isamu, Boku, Narikazu, Hyodo, Ichinosuke

Volltext

O5-3 Expert training workshop on support for balancing cancer treatment and work organized by West Japan Oncology Group von Ikeda, Satoshi, Ozawa, Yuichi, Nagase, Michitaka, Aogi, Kenjiro, Onishi, Koji, Hosoda, Etsuko, Tateishi, Seiichiro, Takahashi, Miyako, Sawa, Toshiyuki

Volltext

Impact of gemcitabine on the treatment of metastatic pancreatic cancer von ISHII, HIROSHI, FURUSE, JUNJI, NAGASE, MICHITAKA, YOSHINO, MASAHIRO

Volltext

O14-1 A randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer: WJOG8315G von Makiyama, Akitaka, Shoji, Hirokazu, Kawakami, Hisato, Tamura, Takao, Sugiyama, Keiji, Hara, Hiroki, Nagase, Michitaka, Nishikawa, Kazuo, Esaki, Taito, Izawa, Naoki, Nakamura, Masato, Ando, Takayuki, Miura, Yuji, Narita, Yukiya, Shimokawa, Mototsugu, Yamazaki, Kentaro, Hironaka, Shuichi, Hyodo, Ichinosuke, Muro, Kei

Volltext

A clinicopathological study of basaloid squamous carcinoma of the esophagus von Saito, Shin, Hosoya, Yoshinori, Zuiki, Toru, Hyodo, Masanobu, Lefor, Alan, Sata, Naohiro, Nagase, Michitaka, Nakazawa, Masanori, Matsubara, Daisuke, Niki, Toshiro, Yasuda, Yoshikazu

Volltext

Early Phase II Study of Uracil–Tegafur Plus Doxorubicin in Patients with Unresectable Advanced Biliary Tract Cancer von Furuse, Junji, Okusaka, Takuji, Funakoshi, Akihiro, Yamao, Kenji, Nagase, Michitaka, Ishii, Hiroshi, Nakachi, Kohei, Ueno, Hideki, Ikeda, Masafumi, Morizane, Chigusa, Horikawa, Yuki, Mizuno, Nobumasa

Volltext

Chemotherapy in the Treatment of Advanced Gallbladder Cancer von Ishii, Hiroshi, Furuse, Junji, Yonemoto, Naohiro, Nagase, Michitaka, Yoshino, Masahiro, Sato, Tosiya

Volltext

A randomized phase II trial of paclitaxel plus ramucirumab versus nab-paclitaxel plus ramucirumab for gastric cancer with peritoneal dissemination refractory to first-line therapy... von Hirata, Kenro, Hamamoto, Yasuo, Shoji, Hirokazu, Hara, Hiroki, Kondoh, Chihiro, Yasui, Hisateru, Kajiwara, Takeshi, Baba, Eishi, Ando, Takayuki, Sugimoto, Naotoshi, Okano, Naohiro, Kawakami, Hisato, Katsuya, Hiroo, Nagase, Michitaka, Moriwaki, Toshikazu, Yoshimura, Kenichi, Ando, Masahiko, Yamazaki, Kentaro, Hironaka, Shuichi, Muro, Kei

Volltext

A patient with esophageal squamous cell carcinoma who had a complete pathological response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil von Ui, Takashi, Nagase, Michitaka, Hosoya, Yoshinori, Kurashina, Kentaro, Haruta, Hidenori, Zuiki, Toru, Yasuda, Yoshikazu, Ura, Takashi, Muro, Kei, Fujii, Hirofumi

Volltext

Advances in Immune Checkpoint Inhibitor That Physicians Need to Know von Nakamura, Mashio, Yasuda, Hideo, Kitano, Shigehisa, Minemura, Nobuyoshi, Nagase, Michitaka, Koshimizu, Naoki, Mori, Ichiro

Volltext